It remains difficult to bet against J&J in the long term Near-term challenges around currency and inflation will linger into 2023 Investors probably shouldn’t rush to...
U.K.’s pharmaceutical stocks offer a buying opportunity in the current economic upheaval, given their defensive nature and the vast global footprint GSK has become a leaner...
Recently spun off from global health giant GlaxoSmithKline (NYSE:GSK), Haleon (NYSE:HLN) is a powerhouse. The provider of over-the-counter medicines and treatments has sales in...
Moderna (NASDAQ:MRNA), one of the most-loved stocks this year, has lost some of its charm. Its shares are now under pressure as many analysts warn that the rally in the COVID...
After its more than 450% surge during 2020, the meteoric rally in Moderna (NASDAQ:MRNA) shares continues this year. The gains—propelled by the biotech's breakthrough vaccine...
Vaccines manufactured by three groups have so far been approved in the UK. They include:AstraZeneca (LON:AZN) (NASDAQ:AZN)/ Oxford University; BioNTech (NASDAQ:BNTX) / Pfizer...
Investing concepts, including environmental, social and governance (ESG) investing, socially-responsible investing (SRI) and impact investing, have become important features of the...
The year 2020 has not been kind to the oil industry. Brent crude, the international benchmark, started the year around $60. By late April, it was below $20. When various lockdowns...
The COVID-19 pandemic has created several equity market winners, including pharma giant AstraZeneca (LON:AZN) (NYSE:AZN). The company, along with its partner Oxford University, is...
Earlier this month, the Office for National Statistics (ONS) officially declared the UK economy in recession. It marked the first time since the 2008-09 financial crisis that the...